SenoRx Prices IPO

Aliso Viejo-based SenoRx has priced its IPO, saying today that it will offer 5,500,000 shares of its common stock at $8.00 per share. SenoRx will trade on the Nasdaq Global Market as "SENO". The firm's IPO is being underwritten by Bank of America Securities, Citigroup Markets, Cowen and Company, and Canaccord Adams. SenoRx is developing medical diagnostics for breast cancer, and is venture backed by CIT Venture Capital, DeNovo Ventures, Domain Associates, Mayfield, and MPM Capital.